Clinical Research

A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress

ESC Congress 2023 to feature 30 late-breaking clinical trials

The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.

diagnostic accuracy

Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Serious discrepancies between preliminary imaging reads and final radiology reports are at risk of accumulating when the prelims are rendered during overnight hours. 

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

PCI

Colchicine before PCI: New research tracks the long-term impact on heart health

Researchers shared long-term follow-up data from the Colchicine-PCI trial, which compared colchicine administration before PCI with a placebo.

SCCT 2023 poster presentations

New research on AI-based CCTA assessments wins Best Abstract at SCCT 2023

Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up. 

Peter Libby, MD, explains how infections cause heart attacks. This came out of research taking a close look at COVID, but the inflammation from any infection may cause increased inflammation of coronary plaques that cause heart attacks. #COVID #COVID19

Do infections cause heart attacks? Lessons from COVID

COVID-19 opened the eyes of many cardiology researchers that infections may promote inflammation in atherosclerotic plaques, leading to cardiac events.

Harvard 3D printed heart muscles

Harvard researchers unlock the secret to building 3D-printed heart muscles that can beat

Creating these complex structures with 3D printing alone has never been possible—until now. 

Thumbnail

Deep learning detects precancerous changes on mammograms

What’s more, the model proved beneficial in a large, diverse cohort that included women with benign breast disease and BRCA mutations.